CHLOE PACHECO: Open Payments
NPI 1831802164 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,224 in 42 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $2,186 · 2025 $1,224
Food & beverage: $1,224
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $408 |
| GlaxoSmithKline, LLC. | 6 | $230 |
| Novartis Pharmaceuticals Corporation | 5 | $114 |
| BioCryst US Sales Co., LLC | 5 | $112 |
| Regeneron Healthcare Solutions, Inc. | 4 | $94 |
| GENZYME CORPORATION | 3 | $56 |
| Cycle Pharmaceuticals Inc | 2 | $54 |
| Amgen Inc. | 2 | $44 |
| Blueprint Medicines Corporation | 1 | $24 |
| CSL Behring | 1 | $24 |
Products named: TEZSPIRE, NUCALA, DUPIXENT, ORLADEYO, FASENRA, XOLAIR, Sajazir, TRELEGY ELLIPTA.
Industry payments across NM — which companies pay providers there.
